ID

15114

Beschreibung

Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet; ODM derived from: https://clinicaltrials.gov/show/NCT00118950

Link

https://clinicaltrials.gov/show/NCT00118950

Stichworte

  1. 16.05.16 16.05.16 -
Hochgeladen am

16. Mai 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT00118950

Eligibility Diabetes Mellitus, Type 2 NCT00118950

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type-2 diabetes, defined as:
Beschreibung

diabetes type 2

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
age at onset of diabetes ≥ 40 years
Beschreibung

age at onset

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0332162
fasting serum c-peptide ≥ 300 pmol/l or a non-fasting or glucagon-stimulated serum c-peptide ≥ 600 pmol/l
Beschreibung

serum c-peptide

Datentyp

boolean

Alias
UMLS CUI [1]
C0006558
no history of ketonuria or ketoacidosis .
Beschreibung

ketonuria or ketoacidosis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0162275
UMLS CUI [1,2]
C0011880
bmi ≤ 27 kg/m2.
Beschreibung

bmi

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
fasting plasma-glucose ≥ 6.5 mmol/l after at least one month of diet-only treatment.
Beschreibung

plasma-glucose

Datentyp

boolean

Alias
UMLS CUI [1]
C0202042
hba1c ≤ 9.5% at ongoing oral anti-hyperglycaemic agents. hba1c ≥ 6.5% after minimum one month of diet-only treatment.
Beschreibung

hba1c

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
weight-loss of no more than 5.0 kg during the last 6 months prior to enrolment.
Beschreibung

weight-loss

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1262477
UMLS CUI [1,2]
C0439792
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
type-1 diabetes
Beschreibung

diabetes type 1

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441729
insulin-treated type-2 diabetes
Beschreibung

diabetes type

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
UMLS CUI [1,3]
C0745343
secondary diabetes, heart-failure
Beschreibung

diabetes

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0277555
UMLS CUI [1,3]
C0018801
serum-creatinine above the upper limit
Beschreibung

creatinine

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
serum-asat elevated more than 3 fold above the upper limit
Beschreibung

asat

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
factor ii-vii-x decreased below 0.7
Beschreibung

blood coagulating factor

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005789
UMLS CUI [1,2]
C0547047
ongoing coexisting illnesses with a life-shortening prognosis
Beschreibung

life shortening comorbidity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0023671
mental retardation or reduced intellectual behaviour
Beschreibung

mental retardation

Datentyp

boolean

Alias
UMLS CUI [1]
C0025362
pregnancy
Beschreibung

pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
history of drug-abuse or hba1c>10.5% at two separate visits with at least one month interval during treatment-periods.
Beschreibung

drug-abuse

Datentyp

boolean

Alias
UMLS CUI [1]
C0013146
UMLS CUI [2]
C0019018

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT00118950

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
diabetes type 2
Item
type-2 diabetes, defined as:
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
age at onset
Item
age at onset of diabetes ≥ 40 years
boolean
C0001779 (UMLS CUI [1,1])
C0332162 (UMLS CUI [1,2])
serum c-peptide
Item
fasting serum c-peptide ≥ 300 pmol/l or a non-fasting or glucagon-stimulated serum c-peptide ≥ 600 pmol/l
boolean
C0006558 (UMLS CUI [1])
ketonuria or ketoacidosis
Item
no history of ketonuria or ketoacidosis .
boolean
C0162275 (UMLS CUI [1,1])
C0011880 (UMLS CUI [1,2])
bmi
Item
bmi ≤ 27 kg/m2.
boolean
C1305855 (UMLS CUI [1])
plasma-glucose
Item
fasting plasma-glucose ≥ 6.5 mmol/l after at least one month of diet-only treatment.
boolean
C0202042 (UMLS CUI [1])
hba1c
Item
hba1c ≤ 9.5% at ongoing oral anti-hyperglycaemic agents. hba1c ≥ 6.5% after minimum one month of diet-only treatment.
boolean
C0019018 (UMLS CUI [1])
weight-loss
Item
weight-loss of no more than 5.0 kg during the last 6 months prior to enrolment.
boolean
C1262477 (UMLS CUI [1,1])
C0439792 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
diabetes type 1
Item
type-1 diabetes
boolean
C0011849 (UMLS CUI [1,1])
C0441729 (UMLS CUI [1,2])
diabetes type
Item
insulin-treated type-2 diabetes
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
C0745343 (UMLS CUI [1,3])
diabetes
Item
secondary diabetes, heart-failure
boolean
C0011849 (UMLS CUI [1,1])
C0277555 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,3])
creatinine
Item
serum-creatinine above the upper limit
boolean
C0201976 (UMLS CUI [1])
asat
Item
serum-asat elevated more than 3 fold above the upper limit
boolean
C0201899 (UMLS CUI [1])
blood coagulating factor
Item
factor ii-vii-x decreased below 0.7
boolean
C0005789 (UMLS CUI [1,1])
C0547047 (UMLS CUI [1,2])
life shortening comorbidity
Item
ongoing coexisting illnesses with a life-shortening prognosis
boolean
C0009488 (UMLS CUI [1,1])
C0023671 (UMLS CUI [1,2])
mental retardation
Item
mental retardation or reduced intellectual behaviour
boolean
C0025362 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
drug-abuse
Item
history of drug-abuse or hba1c>10.5% at two separate visits with at least one month interval during treatment-periods.
boolean
C0013146 (UMLS CUI [1])
C0019018 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video